p63 heterozygous mutant mice are not prone to spontaneous or chemically induced tumors.
Homology between p63 and p53 has suggested that these proteins might function similarly. However, the majority of data from human tumors have not supported a similar role for p63 in tumor suppression. To investigate this issue, we studied spontaneous tumorigenesis in p63+/- mice in both WT and p53-compromised backgrounds. We found that p63+/- mice were not tumor prone and mice heterozygous for both p63 and p53 had fewer tumors than p53+/- mice. The rare tumors that developed in mice with compromised p63 were also distinct from those of p53+/- mice. Furthermore, p63+/- mice were not prone to chemically induced tumorigenesis, and p63 expression was maintained in carcinomas. These findings demonstrate that, in agreement with data from human tumors, p63 plays a markedly different biological role in cancer than p53.
Keyes
William M
WM
Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724, USA.
Vogel
Hannes
H
Koster
Maranke I
MI
Guo
Xuecui
X
Qi
Yi
Y
Petherbridge
Kristin M
KM
Roop
Dennis R
DR
Bradley
Allan
A
Mills
Alea A
AA
D000818:Animals; D002273:Carcinogens / Q000494:pharmacology; D004198:Disease Susceptibility; D015972:Gene Expression Regulation, Neoplastic; D042822:Genomic Instability / Q000235:genetics; D006579:Heterozygote; D051379:Mice; D018345:Mice, Knockout; D008969:Molecular Sequence Data; D009154:Mutation / Q000235:genetics*; D009369:Neoplasms / Q000139:chemically induced* / Q000235:genetics / Q000378:metabolism / Q000473:pathology*; D010750:Phosphoproteins / Q000172:deficiency / Q000235:genetics* / Q000378:metabolism*; D015534:Trans-Activators / Q000172:deficiency / Q000235:genetics* / Q000378:metabolism*
D002273:Carcinogens; D010750:Phosphoproteins; D015534:Trans-Activators; C486419:Trp63 protein, mouse